Company Directory

E3D's autoinjectors and patch pumps are for conventional drugs, biologics and biosimilars. It offers autoinjectors that are compatible with drugs in vials, prefilled syringes and cartridges, and also disposable and reusable autoinjectors. E3D emphasises customisability and flexibility.

Eco-inject is a start-up injection device company focused on reducing the carbon footprint of medical products, while maintaining optimal usability features. It has extensive knowledge and experience of developing drug delivery devices.

EdgeOne Medical is a contract device development organisation that supports the compliant device development and testing of combination products. Since 2012, it has been elevating medical device and combination product development teams including in >10 of the global top-20 biopharma firms.

Eitan Medical develops drug delivery systems, including wearable injectors and infusion solutions, that put patients at the centre of care, making drug delivery easier and safer. The devices are applied across the continuum of care, including hospital, ambulatory and home-care environments.

Elektrofi is a biotechnology company developing technologies, including Elektroject™, that enable protein therapeutics to be conveniently administered to patients in small-volume syringe injections instead of large-volume IV infusions or frequent injections.

Emergo by UL is a regulatory consultancy specialising in medical device, combination product and IVD compliance.  Its human factors research & design (HFR&D) global team specialises in early-stage user research, product design, usability testing and user interface design.

EmulTech develops microspheres which can be used for controlled and sustained release, the delivery of poorly soluble APIs, to provide taste masking, to enable targeted delivery; and to improve stability. The company's process enables tight control over particle size and other characteristics.

Enable Injections is developing the enFuse™ discreet, convenient, body-worn injection device. It is compatible with any standard container closure system, including a syringe or vial and allows self-administration of high-volume (up to 50 mL) and/or high-viscosity therapeutics.

Encompass Ophthalmic Development, part of Encompass Pharmaceutical Services, offers services including preclinical support, drug development, reformulation, to improved product characteristics. Drug delivery system development is included in its service offering.